Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.
Approximately 30-40% of the patients with early stage non-small cell lung cancer (NSCLC) will present with recurrent disease within two years of resection. Here, we performed extensive galectin expression profiling in a retrospective study using frozen and paraffin embedded tumor tissues from 87 sta...
Guardado en:
Autores principales: | Iris A Schulkens, Roy Heusschen, Vivian van den Boogaart, Robert-Jan van Suylen, Anne-Marie C Dingemans, Arjan W Griffioen, Victor L Thijssen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67e46d41674a4581ba2c9e7c25de27bb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Does Diabetes Alter Immunolocalization of Galectin-1 and Galectin-3 in the Rat Ovary?
por: Özdenoglu,Berna, et al.
Publicado: (2016) -
Galectin-3 as a prognostic biomarker for diabetic nephropathy
por: Hodeib H, et al.
Publicado: (2019) -
Galectin-3 Inhibits Galectin-8/Parkin-Mediated Ubiquitination of Group A Streptococcus
por: Yi-Lin Cheng, et al.
Publicado: (2017) -
The role of Galectin-1 and Galectin-3 in the mucosal immune response to Citrobacter rodentium infection.
por: Renata Curciarello, et al.
Publicado: (2014) -
Galectin-9 expression correlates with therapeutic effect in rheumatoid arthritis
por: Jiao Sun, et al.
Publicado: (2021)